Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Navinci

Explore full profile

Company that develops proprietary technology for detecting and quantifying proteins, protein interactions

Uppsala kommun, SwedenFounded 2004Biotech & Life Sciences
Valuation $25–50M Last recorded · 2025
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Navinci and the history behind them.

About Navinci

Navinci is a Swedish biotech company that specializes in developing cutting-edge solutions for studying protein interactions. The company operates in the life sciences and biotechnology market, providing tools and kits based on their proprietary in situ Proximity Ligation Technology. This technology enables researchers to precisely detect proteins, protein-protein interactions, and protein modifications in various sample types, including cultured cells, fresh frozen, and FFPE samples. Navinci's core product offerings include a range of kits that can be used with one or two primary antibodies and feature Navenibodies for secondary detection. These kits are designed to provide accurate, quantifiable, and precise staining, making them invaluable for researchers in cell biology and spatial proteomics. The company primarily serves academic researchers, pharmaceutical companies, and clinical laboratories that require reliable and innovative tools for visualizing and interpreting protein interplay. Navinci's business model revolves around the sale of these specialized kits and related products, generating revenue through direct sales and partnerships with research institutions and biotech firms.

Source: Dealroom company data

At a glance

Founded
2004
Headquarters
Uppsala kommun, Sweden
Sector
Biotech & Life Sciences

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Segulah Medical
  • Nxt2b
  • Landegren Gene Technology
  • Beijer Ventures

Series B and later2 investors entered at this stage

  • Ulf Landegren
  • Meltwind
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇸🇪 Sweden92%
🇬🇧 United Kingdom4%
🇨🇭 Switzerland4%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Navinci on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Navinci on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.